A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01416259 |
|
Recruitment Status
:
Completed
First Posted
: August 15, 2011
Last Update Posted
: August 4, 2015
|
Sponsor:
Heron Therapeutics
Information provided by (Responsible Party):
Heron Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 2011 |
| Actual Study Completion Date : | October 2011 |